期刊文献+

Twist1基因在A549与A549/DDP细胞中的表达及意义 被引量:1

The Expression of Twist1 Gene in A549 and A549 / DDP Cells and its Significance
下载PDF
导出
摘要 目的检测人Twist1基因在A549与A549/DDP细胞株中的表达,探讨Twist1与肺腺癌顺铂耐药的相关性。方法通过细胞计数,观察不同浓度梯度顺铂干预24 h后A549细胞和A549/DDP细胞的生长情况;用RIPA裂解液裂解A549、A549/DDP细胞,充分游离细胞总蛋白,用BCA法检测总蛋白浓度,ELISA法检测Twist1转录因子的浓度。结果定义m值(m=Twist1转录因子浓度/总蛋白浓度)。浓度为0、10、20、30、40、50 mg·L^(-1)的顺铂干预下,分别测得A549与A549/DDP的m值为3.01/3.31、2.17/2.82、1.63/2.94、1.73/1.99、0.37/1.31、-/-,A549/DDP细胞的m值显著大于A549细胞(P<0.05)。结论 Twist 1基因在人顺铂耐药肺腺癌细胞中表达增高,提示Twist1可能与肺腺癌顺铂耐药相关。 Objective To investigate the relationship between Twist1 and cisplatin resistance in lung adenocarcinoma by detecting the expression of Twist1 gene in A549 cell line and A549/DDP cell line. Methods The growth of A549 cells and A549/DDP cells was observed dynamically before and 24 h after the intervention of cisplatin with different concentration gradients, and cells were counted at the same time. The A549 cells and A549/DDP cells were split by RIPA Lysis Buffer to release the cell total protein completely. The total protein concentration was detected by enhanced BCA Protein Assay Kit, and the concentration of Twist1 transcription factor was detected by ELISA assay. Results The m' was defined as m = concentration of Twist1 transcription factor / concentration of total protein. The m of A549 cells and A549/DDP cells was 3.01/3.31, 2.17/2.82, 1.63/2.94, 1.73/1.99, 0.37/1.31,-/- respectively when intervened by 0, 10, 20, 30, 40, 50 mg·L-1 of cisplatin. The m of A549/DDP cells was significantly higher than that of A549 cells(P0.05). Conclusion Twist 1 gene was highly expressed in human cisplatin-resistant lung adenocarcinoma cells. It may suggest a relationship between Twist1 and cisplatin resistance in lung adenocarcinoma.
出处 《肿瘤药学》 CAS 2016年第2期132-135,共4页 Anti-Tumor Pharmacy
基金 中南大学大学生创新课题C类项目(CY14220)
关键词 肺腺癌 顺铂 耐药性 Twist1基因 Lung adenocarcinoma Cisplatin Drug resistance Twist1
  • 相关文献

参考文献12

  • 1She J, Yang P, Hong Q, et al. Lung cancer in China: challenges and interventions [J]. Chest, 2013, 143(4): 1117-1126. doi: 10. 1378/chest. 11-2948.
  • 2刘雨桃,石远凯,胡兴胜,郝学志,李峻岭,王子平,王燕,王宏羽,张湘茹,孙燕.吉非替尼治疗EGFR基因突变状态不明的青年晚期肺腺癌疗效分析[J].中国肺癌杂志,2014,17(5):401-405. 被引量:12
  • 3Bria E, Cuppone F, Cecere FL, et al. Adjuvant chemothera- py for non-small cell lung cancer [J]. J Thorac Oncol, 2007, 2(5 Suppl): S7-11.
  • 4Kang Y, Massagu6 J. Epithelial-mesenchymal transitions: twist in development and metastasis [J]. Cell, 2004, 118(3): 277-279.
  • 5Ai L, Kim WJ, Alpay M, et al. TRIM29 suppresses TWIST1 and invasive breast cancer behavior [J]. Cancer Res, 2014, 74(17): 4875-4887. doi: 10. 1158/0008-5472. CAN-13-3579.
  • 6Lee KW, Sung CO, Kim JH, et al. CD10 expression is enhanced by Twistl and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo [J]. Int J Cancer, 2015, 136(2): 310-321. doi: 10. 1002/ijc. 29006.
  • 7胡佳,桂艳红,谢平丽,李官成.MicroRNA-33a靶向Twist1调节宫颈癌细胞的侵袭[J].中南大学学报(医学版),2015,40(10):1060-1067. 被引量:6
  • 8李为民,刘丹,卢铀.肺癌诊治水平的进展与提高[J].四川大学学报(医学版),2014,45(2):289-292. 被引量:16
  • 9高原,刘赞,张秀伟,贺佳妮,潘泳岐,郝凤霞,谢玲玲,李庆昌.Wnt/β-catenin信号转导通路与肺腺癌顺铂耐药作用机制研究[J].中华肿瘤防治杂志,2014,21(11):805-810. 被引量:9
  • 10Yin G, Chen R, Alvero AB, et al. TWISTing sternness, in- flammation and proliferation of epithelial ovarian cancer cells through MIRI99A2/214 [J]. Oncogene, 2010, 29(24): 3545-3553.

二级参考文献76

  • 1付燕燕,段昌柱.p_(27)^(kipl)的研究进展[J].重庆医学,2005,34(2):291-293. 被引量:4
  • 2余红,文安智,贾美琳,万自芬.PTEN、p27^(kip1)蛋白在非小细胞肺癌中的表达及意义[J].重庆医学,2005,34(5):711-712. 被引量:4
  • 3Strand TE. Malayeri C. Eskonsipo PK. et al. Adolescent smoking and trends in lung cancer incidence among young adults in Norway 1954-1998. Cancer Causes Control. 2004; 15 (1) : 27-33.
  • 4Marugame T. Yoshimi I. Kamo K. et al. Trends in lung cancer mortality among young adults in Japan. Ipn J Clin Oncol , 2005; 35( 4) : 177-180.
  • 5NCCN guidelines version 1. 2014. Non-small cell lung cancer. Naional Comprehensive Cancer Network. 2013. Available at www. nccn. argo.
  • 6Blanchon T. Brechot JM. Grenier PA. et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer.2007;58(1) :50-58.
  • 7Tammemagi MC. Katki HA. Hocking WG. et al. Selection criteria for lung-cancer screening. N Engl J Med.2013;368(8): 728-736.
  • 8Henschke CI. Early lung cancer action project: overall design and findings from baseline screening. Cancer. 2000; 89 ( 11 Suppl) : 2474-2482.
  • 9Saghir Z. Dirksen A. Ashraf H. et al. CT screening for lung cancer brings forward early disease. The randomised Danish lung cancer screening trial: status after five annual screening rounds with low-dose CT. Thorax.2012;67(4) :296-301.
  • 10Becker N. Motsch E. Gross ML. et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol , 2012; 138( 9) : 1475-1486.

共引文献44

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部